Integration of size-exclusion chromatography and ultracentrifugation for purification of recombinant hepatitis B surface antigen: An alternative method for immunoaffinity chromatography

Prep Biochem Biotechnol. 2019;49(2):158-166. doi: 10.1080/10826068.2018.1550658. Epub 2019 Jan 13.

Abstract

In purification process of recombinant hepatitis B surface antigen (rHBsAg), immunoaffinity chromatography (IAF) is one of the most important and effective steps in rHBsAg purification. However, the buffer composition and the interaction of ligands-rHBsAg often lead to disassembly, deformation, and clumping of a portion of these virus-like particles (VLPs). Besides, the expensive media, variable biospecific ligand density and the possibility of product contamination are other reported drawbacks of using IAF which makes the production process of rHBsAg more challenging. This study investigated the possibility of substituting IAF with purification methods of size-exclusion chromatography (SEC) and ultracentrifugation. In the SEC, the efficacy of rHBsAg purification was examined by four different media in which Toyopearl HW 65S resin demonstrated the best results. By integrating Toyopearl HW 65S resin - with a bed height of 51 cm - and ultracentrifugation process at 47,000 rpm for 48 hr, 95% of protein impurities were removed. Compared to the IAF in rHBsAg production, the purified sample contained a higher percentage of multimeric rHBsAg particles without any noticeable monomer and aggregate forms. The result of this study indicates that the proposed integrated system could be an efficient mild purification alternative for conventional IAF.

Keywords: Alternative purification techniques; chromatography resins; rHBsAg; size-exclusion chromatography; ultracentrifugation; virus-like particles stability.

MeSH terms

  • Chromatography, Affinity
  • Chromatography, Gel / methods*
  • Hepatitis B / virology
  • Hepatitis B Surface Antigens / isolation & purification*
  • Hepatitis B virus / chemistry
  • Humans
  • Pichia / chemistry
  • Recombinant Proteins / isolation & purification
  • Ultracentrifugation / methods*

Substances

  • Hepatitis B Surface Antigens
  • Recombinant Proteins